Serum anti-PLA2R antibodies and PLA2R1 gene polymorphisms in a sample of Iraqi patients with membranous nephropathy
Scripta Medica · 2026 · 57 (5) · 1065-1072
DOI: 10.5937/scriptamed57-67631 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scripta Medica, 2026. Verfasst von Sahar Ibrahim und 4 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Aim: Membranous nephropathy (MN) is a leading cause of nephrotic syndrome in adults. Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and PLA2R1 variants are associated with primary MN, but data from Iraq are limited. This study compared biochemical parameters, serum anti-PLA2R levels and PLA2R1 variants in Iraqi patients with MN and healthy controls.
Methods
Laboratory measurements were reported for 50 patients with MN undergoing maintenance haemodialysis and 50 apparently healthy controls. Patient samples were collected before dialysis at Al-Kindy Teaching Hospital, Baghdad, Iraq. Complete blood count and biochemical parameters were measured using automated analysers and serum anti-PLA2R levels were measured by sandwich enzyme-linked immunosorbent assay. DNA from 25 patients and 25 controls was analysed by polymerase chain reaction and sequencing.
Results
Patients had lower serum albumin, calcium, iron and haemoglobin and higher creatinine, urea, alkaline phosphatase, phosphate, ferritin, biliru-bin and anti-PLA2R levels (all p < 0.05). Anti-PLA2R levels differed between groups (p < 0.001), with an area under the receiver operating characteristic curve of 1.000, but were not significantly correlated with creatinine (r = -0.12, p = 0.411). The 33,988 (G>A) variant had a reported odds ratio (OR) of 6.78 (p = 0.041), while 34,046 (G>A) had an OR of 0.07 (p < 0.001). No significant asso-ciation was found at 33,861 or 34,254. In the multivariable model, anti-PLA2R level had the largest reported OR (17.6; p < 0.001).
Conclusion
Serum anti-PLA2R levels showed strong discrimination be-tween patients and healthy controls in this dataset. Associations with selected PLA2R1 variants warrant further investigation before clinical or causal conclu-sions are drawn.
Zitieren
APA
Ibrahim, S., Mohammed, D., Abd, F., Mahmoud, O., & Salih, A. (2026). Serum anti-PLA2R antibodies and PLA2R1 gene polymorphisms in a sample of Iraqi patients with membranous nephropathy. Scripta Medica, 57(5), 1065-1072. https://doi.org/10.5937/scriptamed57-67631
Vancouver
Ibrahim S, Mohammed D, Abd F, Mahmoud O, Salih A. Serum anti-PLA2R antibodies and PLA2R1 gene polymorphisms in a sample of Iraqi patients with membranous nephropathy. Scripta Medica. 2026;57(5):1065-1072. doi:10.5937/scriptamed57-67631
BibTeX
@article{Ibrahim2026,
author = {Ibrahim, Sahar and Mohammed, Dunya and Abd, Farah and Mahmoud, Omar and Salih, Arwa},
title = {Serum anti-PLA2R antibodies and PLA2R1 gene polymorphisms in a sample of Iraqi patients with membranous nephropathy},
journal = {Scripta Medica},
year = {2026},
volume = {57},
number = {5},
pages = {1065--1072},
doi = {10.5937/scriptamed57-67631}
}
EUVIMED